2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

»çȸ¹®Á¦¸¦ ÇØ°áÇϴ û³â 478¸íÀÇ ¡®º£À̽ºÄ·ÇÁ¡¯°¡ µÇ´Ù

10³â°£ 478¸íÀÇ ¼ö·á»ý ¹èÃ⡦ ÀÓÆÑÆ® »ýŰè ÀÎÀç µî¿ë¹® ¿ªÇÒ
ºñ¿µ¸® »ç´Ü¹ýÀÎ ·çÆ®ÀÓÆÑÆ®°¡ ‘ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ(Impact Basecamp)’ ÇÁ·Î±×·¥ 10ÁÖ³âÀ» ¸Â¾Æ ¼ö·á»ýÀÇ º¯È­¿Í ÇÁ·Î±×·¥ÀÇ ¼º°ú¸¦ ´ãÀº ÀÓÆÑÆ® ¸®Æ÷Æ®¸¦ ¹ß°£ÇÏ°í ±â³äÇà»ç¸¦ °³ÃÖÇß´Ù. ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ´Â û³âµéÀÌ »çȸ¹®Á¦¸¦ ÇØ°áÇÏ´Â ¿ª·®À» ±â¸£°í, À̸¦ Ä¿¸®¾î ¼ºÀå°ú ¿¬°èÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â ±³À° ÇÁ·Î±×·¥ÀÌ´Ù. ¾à 8ÁÖ~16ÁÖ°£ »çȸ¹®Á¦¸¦ Á¤ÀÇÇϰí Á÷Á¢ ¹®Á¦ ÇØ°á ¹æ¹ýÀ» µµÃâÇÏ´Â ÇÁ·ÎÁ§Æ® ±â¹Ý ÇнÀ(Project Based Learning, PBL) ¹æ½ÄÀ¸·Î ÁøÇàµÈ´Ù. 2015³â ½ÃÀÛÇÑ ÀÌ·¡ ÇöÀç±îÁö 478¸íÀÇ ¼ö·á»ýÀ» ¹èÃâ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¸¶¸£½Ã½º, ÄÚµù ·Îº¿ ´ë½Ã ½ºÆ®·Îºñ ¼±º¸¿© (2019-09-10)
¼ÁÅæ, ¶óÀÌ´Ù Çõ½ÅÀ¸·Î 2°³ »ó ¼ö»ó (2021-08-29)
¡®¸ð¹ÙÀÏ ¼Ö·ç¼Ç¡¯ ÄÚÄھƾÚ, ±¹³» ÃÖÃÊ Áß±¹ ÁøÃâ (2013-10-02)
ġŲ Æú¸®½º °É½ºµ¥ÀÌ CF È­Á¦ (2013-09-20)
Ãß¼® ¼º¼öǰ ¼ö±Þ ¾ÈÁ¤ ´ëÃ¥ ÃßÁø (2019-08-29)
¹ÙÀÌ¿À¼Ö·ç¼Ç, ÁÖ¿ä Çٽɻç¾÷ ¿ª·® °­È­ ³ª¼±´Ù (2019-08-17)
Ú¸ Á¸½¼¾Ø¿þÀÏÁîÓÞ, ¿ä¸® À¯ÇС¤Á¦°úÁ¦»§ À¯ÇÐ ¼³¸íȸ (2019-07-24)
CMS ¿µÀç±³À°¼¾ÅÍ, ½ÅÀÔ»ý ¸ðÁý ÀÔÇÐÀüÇü (2021-07-24)
Á¦Á¶¾÷ ¸£³×»ó½º À̲ø Çõ½Åº¥Ã³ Ű¿î´Ù (2019-06-30)
°­¿øµµ, Á¦´ë±ºÀÎÀÇ Áö¿ª»çȸ ¾ÈÁ¤ÀûÀÎ Á¤Âø Áö¿ø (2013-03-24)
º¸À× 737 Ãß¶ô»ç°í À̽´ ¾Ç¿ë ¾Ç¼ºÄÚµå ÁÖÀǺ¸ (2019-03-26)
For Second Year in a Row, Hillstone Networks Recognized by G... (2021-04-19)
Çö´ëÂ÷¼­ºñ½º ³ë»ç, ¾Æµ¿±¸È£À§ÇØ Â÷·® ±âÁõ (2021-02-06)
¡®Å°´Ù¸®¾ÆÀú¾¾¡¯, 1¿ù Áß IOS ¼­ºñ½º Ãâ½Ã (2021-01-13)
»õ·Î¿î VPN ±â¼ú·Î Áß±¹ÀÇ °Å´ë ¹æÈ­º® °³¹æ (2014-01-29)
SNS ÀÌ¿ë, ½ÅÁ¾¼ö¹ýÀ¸·Î ÁøÈ­Çϴ ¦Åü°Å·¡ (2013-12-24)
±×¸²Ã¥ µðÀÚÀεµ ÀΰøÁö´ÉÀÌ ÇÑ´Ù (2020-12-08)
°æ·Â»ç¿ø ä¿ë ½Ã, ¡®¸éÁ¢¡¯ÀÌ °¡Àå Áß¿ä (2013-11-06)
ÇÁ·£Â÷ÀÌÁî ¹Ú¶÷ȸ Áß½ÉÀÌ ¼­¿ï¿¡¼­ ÀÏ»êÀ¸·Î (2013-10-25)
±â¾ÆÂ÷, ½î·»Åä °¡¼Ö¸° 2.5 Åͺ¸ °è¾à °³½Ã (2020-11-02)
ÇǺγëÈ­ ÃËÁø½ÃŰ´Â À½½Ä 3°¡Áö (2013-08-14)
¼öÁö-À̺´Çå, °ÔÀÓ Ä³¸¯ÅÍ ¾î¿ï¸®´Â ¿¬¿¹ÀÎ ³²³à 1À§ ¿Ã¶ó (2013-08-14)
4³â°£ ¹ß·Î ¶Ù¾î Á¦ÀÛÇÑ Á¦ÁÖ¿©Çà ¾Û (2013-07-21)
LSÀü¼±, Àεµ¿¡ 5G ºÎǰ °øÀå Áذø (2020-10-09)
Äڷγª½Ã´ë ¾Ë¹Ù°íÃæ 1À§ ¡°Àå½Ã°£ ¸¶½ºÅ©Âø¿ë¡± (2020-10-09)
       [ÀÌÀü][1]....[3469][3470][3471][3472][3473][3474][3475][3476][3477]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..